Zenas BioPharma CEO buys 60,000 shares
Zenas BioPharma, Inc. Chief Executive Officer Leon O. Moulder Jr. reported an open-market purchase of 60,000 shares of Common Stock.
Rhea-AI Filing Summary
Zenas BioPharma, Inc. Chief Executive Officer Leon O. Moulder Jr. reported an open-market purchase of 60,000 shares of Common Stock. The shares were bought indirectly through an entity associated with him at a weighted average price of $16.88 per share, with individual trade prices ranging from $16.59 to $16.97. After this transaction, that indirect account held 96,928 shares. As of the same date, he also reported 423,155 shares held directly and 1,786,039 additional shares held indirectly through entities where he may be deemed to have voting and dispositive power, while disclaiming beneficial ownership beyond his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 60,000 shares
Net Buy
3 txns
Insider
MOULDER LEON O JR
Role
Chief Executive Officer
Bought
60,000 shs ($1.01M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock | 60,000 | $16.88 | $1.01M |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 1,882,967 shares (Indirect, See Footnote);
Common Stock — 423,155 shares (Direct)
Footnotes (3)
- F1. The price reported is a weighted average price. These shares were purchased in multiple transactions ranging from $16.59 to $16.97, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
- F2. The reporting person is a Trustee of the Leon O. Moulder, Jr. Revocable Trust U/A dtd 9/9/2008 (the "Trust") and may be deemed to have voting and dispositive power over the shares held by the Trust. The reporting person is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
- F3. Leon O. Moulder, Jr. is the Managing Member of Tellus BioVentures LLC ("Tellus") and may be deemed to have sole voting and dispositive power over the shares held by Tellus. Mr. Moulder is the Issuer's chief executive officer and Chairman of its board of directors. The reporting person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Key Figures
Open-market purchase: 60,000 shares
Weighted average purchase price: $16.88/share
Indirect holdings after purchase (account): 96,928 shares
+2 more
5 metrics
Open-market purchase
60,000 shares
Common Stock bought indirectly on 2026-05-18
Weighted average purchase price
$16.88/share
Open-market trades ranged from $16.59 to $16.97
Indirect holdings after purchase (account)
96,928 shares
Indirect Common Stock position in the purchasing account
Direct holdings
423,155 shares
Common Stock held directly as of 2026-05-18
Other indirect holdings
1,786,039 shares
Common Stock held indirectly through related entities
Key Terms
open-market purchase, weighted average price, voting and dispositive power, beneficial ownership, +1 more
5 terms
open-market purchase financial
"Purchase in open market or private transaction"
An open-market purchase is when an investor or a company buys shares on a public stock exchange at the going market price, rather than through a private deal. It matters to investors because these purchases change how many shares are available, can push the stock price up or signal confidence from large buyers, and often affect per-share metrics like earnings—think of it like someone buying lots of apples off a grocery shelf, reducing supply and potentially raising the price.
weighted average price financial
"The price reported is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
voting and dispositive power financial
"may be deemed to have voting and dispositive power over the shares"
beneficial ownership financial
"The reporting person disclaims beneficial ownership of such securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
pecuniary interest financial
"except to the extent of his pecuniary interest therein."
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Zenas BioPharma (ZBIO) report for Leon O. Moulder Jr.?
Leon O. Moulder Jr. reported buying 60,000 shares of Zenas BioPharma Common Stock in an open-market transaction. The shares were acquired indirectly through an associated entity, increasing that entity’s holdings and reflecting additional exposure to the company’s equity.
What does the weighted average price disclosure mean for the ZBIO CEO’s stock purchase?
The weighted average price of $16.88 reflects multiple trades executed between $16.59 and $16.97. The filing notes the CEO will provide detailed trade-by-trade pricing information to the issuer, security holders, or SEC staff upon request for additional transparency.
AI-generated analysis. How Rhea-AI works. Not financial advice.
